Difluorocarbene radiosynthesis
US-2024383827-A1 · Nov 21, 2024 · US
US10648985B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10648985-B2 |
| Application number | US-201816107762-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 21, 2018 |
| Priority date | Mar 4, 2011 |
| Publication date | May 12, 2020 |
| Grant date | May 12, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Low-copper click chemistry, 1.3-dipolar cycloadditions, and Staudinger ligations for modifying biomolecules is provided. Compositions, methods, and kits relating to low-copper click chemistry, 1.3-dipolar cycloadditions, and Staudinger ligations are also provided.
Opening claim text (preview).
The invention claimed is: 1. A compound of the formula: wherein: A is a carbon; R 1 , R 2 , R 4 , R 5 , and R 6 , are hydrogen; R 3 comprises X-L-, wherein: X is selected from a reporter molecule, a carrier molecule, a solid support, and a reactive group, that are optionally bound to one or more additional fluorophores, wherein: the reporter molecule comprises a chromophore, a fluorophore, a fluorescent protein, a phosphorescent dye, a tandem dye, a particle, a hapten, an enzyme, or a radioisotope; the carrier molecule is an amino acid, a peptide, a protein, an antibody, an antibody fragment, an antigen, a polysaccharide, a nucleoside, a nucleotide, an oligonucleotide, a nucleic acid, a hapten, a psoralen, a hormone, a lipid, a lipid assembly, a tyramine, a synthetic polymer, a polymeric microparticle, a biological cell, a cellular compartment, an ion chelating moiety, an enzymatic substrate, or a virus; the solid support is an aerogel, a hydrogel, a resin, a silica gel, a bead, a biochip, a microfluidic chip, a silicon ship, a multi-well plate, a membrane, a polymeric membrane, a particle, a derivatized plastic film, a glass bead, cotton, a plastic bead, alumina gel, polysaccharide, poly(acrylate), polystyrene, poly(acrylamide), polyol, agarose, agar, cellulose, dextran, starch, heparin, glycogen, amylopectin, mannan, inulin, nitrocellulose, diazocellulose, polyvinylchloride, polypropylene, polyethylene, nylon, latex bead, a conducting metal, a nonconducting metal, glass, magnetic bead, paramagnetic bead, superparamagnetic bead, or a magnetic support; the reactive group is a carboxylic acid, an activated ester of carboxylic acid, an amine, a hydrazine, a haloacetamide, an alkyl halide, an isothiocynate or a maleimide group; and L is NH—(CH 2 ) n —NH—C(O)—, wherein n is 1 to 12; Z is a single covalent bond; and G is an azide. 2. The compound of claim 1 , wherein the fluorophore is a xanthene, coumarin, cyanine, pyrene, oxazine, borapolyazaindacene, or carbopyranine. 3. The compound of claim 1 , wherein the enzyme is horseradish peroxidase, alkaline phosphatase, beta-galactosidase, or beta-lactamase. 4. A method of modifying a biomolecule comprising the step of reacting in a solution a biomolecule comprising an azide reactive moiety with a compound of claim 1 to provide a modified biomolecule. 5. The method of claim 4 , wherein the azide reactive moiety comprises a terminal alkyne, an activated alkyne, or triarylphosphine. 6. The method of claim 4 , wherein the biomolecule is a nucleic acid, oligonucleotide, protein, peptide, carbohydrate, polysaccharide, glycoprotein, lipid, hormone, drug, or prodrug. 7. The method of claim 4 , wherein the solution further comprises copper ions. 8. The method of claim 7 , wherein the method further comprises at least one reducing agent. 9. The method of claim 7 , wherein the method further comprises a copper chelator. 10. A kit comprising a compound of claim 1 . 11. The kit of claim 10 , wherein the kit further comprises a copper ion source. 12. The kit of claim 10 , wherein the kit further comprises at least one reducing agent. 13. The kit of claim 10 , wherein the kit further comprises a copper chelator. 14. A compound selected from the group consisting of:
Acids; Esters · CPC title
with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms · CPC title
Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates · CPC title
Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals · CPC title
Amides; Imides · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.